FCGBP Links Hormonal Imbalance and Hepatic Steatosis in PCOS–NAFLD Comorbidity: An Integrative Bioinformatics and Experimental Study - Takeaways - MDSpire

FCGBP Links Hormonal Imbalance and Hepatic Steatosis in PCOS–NAFLD Comorbidity: An Integrative Bioinformatics and Experimental Study

  • By

  • Yao, Yi

  • Si, Min

  • Ding, Hongcheng

  • Cao, Chengcheng

  • Yang, Hua

  • Sun, Qianshu

  • April 14, 2026

  • 0 min

Share

  • 1

    PCOS and NAFLD are common endocrine-metabolic disorders with significant comorbidity, yet their molecular mechanisms are not well understood.

  • 2

    The study utilized transcriptomic datasets and machine learning algorithms to identify FCGBP as a key gene in PCOS-NAFLD comorbidity.

  • 3

    In a rat model, FCGBP expression was significantly increased in ovarian and hepatic tissues, indicating its role in both conditions.

  • 4

    FCGBP silencing in KGN cells restored estrogen secretion and affected key metabolic enzymes, while in HepG2 cells it reduced lipid accumulation.

  • 5

    The findings suggest FCGBP as a potential molecular regulator for hormonal and metabolic dysfunctions in PCOS-NAFLD comorbidity.

Original Source(s)

Related Content